Dr. Daly is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
1800 American Boulevard
Pennington, NJ 08534Phone+1 609-730-2877
Education & Training
University College of Dublin National Univ SOMClass of 1990
Certifications & Licensure
TX State Medical License 2007 - 2014
Publications & Presentations
PubMed
- 332 citationsA Double-Blind, Randomized, Placebo-Controlled, Dose-Frequency Study of Intravenous Ketamine in Patients With Treatment-Resistant DepressionJaskaran Singh, Maggie Fedgchin, Ella J. Daly, Peter de Boer, Kimberly Cooper
The American Journal of Psychiatry. 2016-04-08 - 285 citationsIntravenous Esketamine in Adult Treatment-Resistant Depression: A Double-Blind, Double-Randomization, Placebo-Controlled Study.Jaskaran Singh, Maggie Fedgchin, Ella Daly, Liwen Xi, Caroline Melman
Biological Psychiatry. 2016-09-15 - 93 citationsPsychiatric symptomatology and prodromal Alzheimer's disease.Maura Copeland, Ella Daly, Virginia Hines, Carol A. Mastromauro, Deborah Zaitchik
Alzheimer Disease and Associated Disorders. 2003-01-01
Authored Content
- Adjunctive Intranasal Esketamine in Treatment-Resistant Depression—ReplyJuly 2018
- S114. Efficacy and Safety of Intranasal Esketamine plus an Oral Antidepressant in Elderly Patients with Treatment-Resistant DepressionApril 2018
Press Mentions
Spravato Debate Still RagesFebruary 20th, 2020
Intranasal Esketamine plus Antidepressant Deflects RelapseJune 13th, 2019- Durability Seen for Esketamine's Benefit in DepressionJune 5th, 2019
- Join now to see all
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
